Shabaninejad Hosein, Yusefzadeh Hasan, Mehralian Gholamhossein, Rahimi Bahlol
Department of Health Services Management, School of Health Management and Information Sciences, Iran University of Medical Sciences, Tehran, Iran.
Department of Public Heath, School of Health, Social Determinants of Health Research Center, Urmia Medical Sciences University, Urmia, Iran.
Iran J Pharm Res. 2019 Winter;18(1):546-555.
Iran`s pharmaceutical products market has faced fluctuations over time. Suitable market selection is necessary for stability of pharmaceutical exports. This study aimed to determine the structure of the world pharmaceutical market and to identify the target of Iranian pharmaceutical export. T do so, concentration ratios and Herfindahl index were used to address the world pharmaceutical market from 2001 to 2012. Also, a composite index was used to identify the target markets of Iran's pharmaceutical industry. The results showed that the export side of world pharmaceutical trade has shifted to open oligopoly, thereby decreasing the monopolistic power of exporters. The import side, however, follows monopolistic competition. It has been observed that the structure of Iran's pharmaceutical export is shifting to open oligopoly; though, pharmaceutical importers from Iran have not been stable. Moreover, 27 countries were identified as target markets. Due to significant differences between the current and potential export destinations of Iran's pharmaceutical products, exporters should choose suitable strategies in order to diversify export markets. Such mechanisms as setting preferential tariffs on the basis of bilateral agreements, following effective advertisment, and paying attention to global consumers'preferences can be used to develop Iran's pharmaceutical export to target countries.
伊朗的药品市场长期以来一直面临波动。合适的市场选择对于药品出口的稳定至关重要。本研究旨在确定世界药品市场的结构，并确定伊朗药品出口的目标。为此，使用集中度比率和赫芬达尔指数来分析2001年至2012年的世界药品市场。此外，还使用了一个综合指数来确定伊朗制药行业的目标市场。结果表明，世界药品贸易的出口方面已转向开放寡头垄断，从而降低了出口商的垄断力量。然而，进口方面则遵循垄断竞争。据观察，伊朗药品出口的结构正在转向开放寡头垄断；不过，伊朗的药品进口商并不稳定。此外，确定了27个国家为目标市场。由于伊朗药品当前和潜在出口目的地之间存在显著差异，出口商应选择合适的策略以实现出口市场多元化。可以采用诸如根据双边协议设定优惠关税、进行有效宣传以及关注全球消费者偏好等机制来发展伊朗对目标国家的药品出口。
